NuScale Power (SMR): Zen Horizon Research Report

Note: This report is compiled from public information available through 2026-06-08, applies the Zen Horizon analytical framework, and does not constitute personalized investment advice.

1. Company Profile: The World's First NRC-Approved SMR Pure-Play Leader, But Commercialization Is at Least 5 Years Out

NuScale Power Corporation (NYSE: SMR.US, hereafter "NuScale" or "the company") is a nuclear technology firm headquartered in Portland, Oregon, focused on the design and commercialization of small modular reactors (SMRs).

The company traces its origins to the IRIS (International Reactor Innovative and Secure) experimental program launched at Oregon State University (OSU) in 2000, and was incorporated as an independent company in 2007. Fluor Corporation (a large U.S. engineering and construction firm, NYSE: FLR) has been its largest shareholder since 2011, holding roughly 50% of the equity.

Core Products:

• NuScale Power Module (NPM): a 77 MWe (60 MWe net, 77 MWe gross) light-water pressurized water reactor (PWR), built to a modular, factory-prefabricated design.

• VOYGR™ plant platform: a multi-module plant configuration built around the NPM, available in typical 4 / 6 / 12-module setups for total outputs of 308 / 462 / 924 MWe.

Key Technical Features:

• Passive safety system: delivers emergency cooling for more than 30 days with no external power or human intervention.

• Factory prefabrication + on-site assembly: modules are assembled and tested inside a manufacturing plant and then shipped to site by rail/ship/truck, which in theory shortens the traditional 6–8 year nuclear plant construction cycle to 2–3 years.

• Small-footprint advantage: a single module occupies about 1/300 the land area of a large nuclear plant and can be deployed on retired coal plant sites or in industrial parks.

Key Milestones:

• September 11, 2020: the NuScale SMR design became the first SMR design to receive a design certification approval (DCA) from the U.S. NRC (Nuclear Regulatory Commission).

• January 2022: listed on the NYSE through a merger with blank-check company Spring Valley Acquisition Corp (SPAC route).

• July 2023: the NRC issued a Final Design Approval (FDA), confirming that NuScale's 12-module 924 MWe plant is cleared for commercial deployment.

Major Setback:

• January 8, 2024: the flagship Carbon Free Power Project (CFPP) was formally canceled. This was to be the first commercial NuScale SMR plant, developed with the Utah Associated Municipal Power Systems (UAMPS) for deployment at Idaho National Laboratory (INL). The cancellation followed an estimated levelized power price that climbed from an initial $58/MWh to $89/MWh, beyond what UAMPS member cities could bear. The event triggered a single-day stock drop of more than 50%.

Current Financial Profile (FY2025 TTM):

• Revenue of $18.7M (mostly consulting service fees plus government research grants)

• EBITDA of -$203.2M (deeply unprofitable)

• Operating margin of -101.8% (losing $2 for every $1 earned)

• Net margin: not disclosed (deeply negative)

• EPS (TTM) of -$2.20

• ROE of -83.05%

• Q1 2026 revenue down 95.8% year over year (business collapsed after the CFPP cancellation)

Current Market Position (2026-06-05 close):

• Share price of $10.50 (down 12.5% on the day, down 25% over the week, down 70% over 12 months)

• Market cap of $3.63B

• P/S TTM of 194.66x (extreme overvaluation)

• P/E not calculable (loss-making)

• EV/EBITDA not calculable (negative EBITDA)

Key Positioning: NuScale is the SMR sector's "first-mover advantage + NRC certification + legacy story" leader, but the company itself remains in an early stage defined by a long R&D cycle and no commercial sales. Its market cap rests entirely on a "future SMR commercialization" narrative, with no direct link to fundamentals.

2. Longitudinal (I): From the OSU Lab to the SPAC Listing (2000-2022)

2.1 OSU Lab Origins (2000-2007)

• 2000: OSU's nuclear engineering department launched the IRIS (International Reactor Innovative and Secure) program, aiming to design an economical, modular, passively safe small reactor.

• 2007: NuScale Power LLC was spun out of OSU as an independent company, with founders Jose Reyes (OSU nuclear engineering professor) and Paul Lorenzini (former U.S. Department of Energy official) serving as early leaders.

2.2 Fluor Acquisition and R&D Phase (2011-2019)

• 2011: Fluor Corporation acquired most of NuScale's equity, becoming its largest shareholder (~50% stake). Fluor provided engineering capability and capital support.

• 2013-2018: signed design-certification cooperation agreements totaling roughly $260M with the U.S. Department of Energy (DOE), supporting the NRC design certification application.

• 2016: signed a LOI with Utah's UAMPS, launching the CFPP project plan.

• January 2018: the NRC accepted NuScale's design certification application.

2.3 NRC Certification and Listing (2020-2022)

• September 2020: the NRC issued the first SMR design certification, a major historic milestone.

• December 2021: signed a merger agreement with Spring Valley Acquisition Corp (SPAC).

• January 2022: the merger closed and the company listed on the NYSE under the ticker SMR, with an initial market cap of about $1.9 billion. The SPAC raised $410M for operations and R&D.

3. Longitudinal (II): The CFPP Flagship Project's "Roller Coaster" and Commercialization Setback (2016-2024)

3.1 CFPP Project Design and Launch (2016-2020)

• 2016: NuScale signed a LOI with UAMPS to deploy a 12-module 924 MWe plant at Idaho National Laboratory (INL), targeting commercial operation in 2029.

• 2020-2021: the project secured DOE funding support and UAMPS member cities signed up to purchase power.

• The estimated levelized power price at the time was $58/MWh, seen as a marker of an "SMR commercialization breakthrough."

3.2 Cost Surge and Project Adjustment (2022-2023)

• Mid-2022: inflation plus rising commodity prices pushed the estimated CFPP levelized power price up to $89/MWh, a huge gap above the UAMPS economic target of $55/MWh.

• 2023: NuScale held multiple rounds of negotiations with UAMPS, including shrinking the project scope (from 12 modules down to 6) and applying for additional federal funding.

3.3 Project Formally Canceled (2024-01)

• January 8, 2024: the CFPP project was formally declared canceled. UAMPS refunded the development fees NuScale had paid, and the project was terminated.

• The stock fell more than 50% that day, dropping from $5.80 to ~$3.00 (pre-split).

• The company subsequently laid off about 28% of its staff (roughly 154 people).

3.4 Strategic Pivot (2024-2026)

After the CFPP cancellation, NuScale shifted its business focus toward:

• International markets: Romania, Poland, Canada, South Korea

• Dedicated SMRs for data centers: engaging directly with hyperscalers

• South Korean Doosan manufacturing joint venture: establishing a module prefabrication plant in South Korea

Current Customer Pipeline (2024-2026):

Key Observation: not a single one of these customers has placed a "firm order" — every contract is at the LOI, research agreement, or FEED stage and can be canceled at any time (as the CFPP case has proven).

4. Longitudinal (III): Financial Performance and Cash Flow

4.1 Revenue and Loss Trajectory (2020-2025)

Key Observations:

• The 2024 revenue of $37M was an anomaly, including a ~$15M one-time gain (a government refund tied to the CFPP termination); sustainable revenue was ~$22M.

• 2025 revenue fell to $18.7M as the commercialization base disintegrated.

• 2026 Q1 revenue was down 95.8% year over year, reflecting an extremely weak commercialization pipeline.

• Cash burn rate: roughly $150–200M annualized.

• At the current cash level, runway is about 9–12 months, requiring another round of financing or an ATM offering.

4.2 Equity Financing and Dilution

• From 2022 to 2024, the company raised ~$300M cumulatively through ATM (At-The-Market) offerings.

• 2024 strategic financing: Fluor partially cashed out, and ENEC (the UAE's nuclear energy company) took a $35M stake.

• Share dilution issue: ~150M shares after the 2022 listing had grown to ~300M shares by the end of 2025 (including Class B conversions).

4.3 Capital Allocation Pressure

• From 2026 to 2028, the company must simultaneously fund: ongoing R&D (design optimization, module design validation)

• capital expenditure on the South Korean Doosan JV plant

• investment in Romania's RoPower FEED project

• maintaining headquarters and sales team operations

• Estimated cumulative cash burn for 2026-2028 is roughly $500–700M, requiring multiple ATM financings.

5. Moat Analysis

5.1 NRC Design Certification (Strong, But Eroding)

• The world's first SMR design to earn NRC design certification (DCA + FDA). This is a real moat: a new entrant would need 5–7 years and $500M–1 billion to complete the certification process.

• But the moat is eroding: BWXT (already a NuScale partner), TerraPower (backed by Bill Gates), X-energy (backed by Amazon), Holtec, KAIROS (backed by Google), and Westinghouse AP300 are all queued for NRC review, and at least 3–5 will obtain a DCA between 2026 and 2028.

5.2 Technical Maturity (Moderately Strong)

• NuScale's design is 100% complete, and all key components have passed testing.

• The factory prefabrication process is largely settled (Doosan's South Korean plant).

• But no complete module has yet operated at a real site — the single largest empirical gap before commercialization.

5.3 Customer Network (Weak)

• All current customers sit at the evaluation / FEED / research stage — there are no firm orders.

• Compared with rivals such as TerraPower (Bill Gates / Microsoft camp) and X-energy (Amazon), NuScale lacks direct hyperscaler ties.

5.4 Regulatory Barriers (Strong, But Industry-Wide)

• NRC certification is a hard threshold for any SMR entering the U.S. market, but it applies to every SMR vendor.

• NuScale's "first-mover" advantage will erode as competitors obtain DCAs one after another.

5.5 Overall Assessment

Overall moat score of 2.5/5 (weak-to-moderate) — NRC certification is a real moat and the technical lead is real, but every "advantage" is in the past tense; the key assets that matter for commercialization (firm orders, an operating reference, stable revenue) do not exist. The company is weaker than traditional large nuclear operators (VST, CEG); relative to TerraPower/X-energy it has higher technical maturity but a weaker ecosystem.

6. Horizontal: Competitive Landscape

6.1 Direct SMR Competitors

6.2 Key Competitive Analysis

• TerraPower (Natrium): Bill Gates-backed, Microsoft strategic partnership, Wyoming demonstration reactor targeting 2030 operation — the strongest rival on "hyperscaler ties + political resources."

• X-energy (Xe-100): Amazon equity stake, Energy Northwest partnership — another winner on hyperscaler ties.

• Rolls-Royce SMR: the solution selected by the UK's GBN — a UK domestic-market monopoly of 5–10 deployments.

• NuScale's only advantage: an NRC-approved design — but at least 3–5 players will obtain equivalent certification between 2026 and 2028, eroding the first-mover advantage.

6.3 NuScale vs. the Hyperscaler Direct-SMR Strategy

The most important industry shift of 2024-2025 is Amazon / Microsoft / Google investing directly in SMR vendors:

• Amazon → X-energy: announced a $500M investment in October 2024 and contracted for eight 80 MWe modules

• Microsoft → TerraPower / Helion: long-term power purchase agreements

• Google → KAIROS: announced an ordering agreement in October 2024

NuScale is absent — no hyperscaler strategic investment or firm order at all. This is the single biggest gap in NuScale's commercialization outlook.

7. Valuation Analysis (Three-Scenario Range)

7.1 The Special Nature of the Valuation Method

Traditional P/E and EV/EBITDA multiples are completely inapplicable to NuScale (negative EPS, negative EBITDA). The valuation methods the market uses:

• Forward P/S multiple (assuming commercial sales over the next 5–10 years)

• SOTP (Sum-Of-The-Parts): estimating the value of the NRC-certified IP plus the equity in the South Korean Doosan JV plant

• Probability-Weighted DCF: accounting for the probability of commercialization success or failure

7.2 Assumptions Implied by the Current Valuation

The current $3.6B market cap implies the following assumptions (back-solved at EV/Sales of 5x and a 15% net margin):

• 2030 revenue of $720M: requires selling ~30 NuScale modules (at ~$200M each) — there are currently no firm orders at all.

• 2030 net income of $108M: corresponding to a forward P/E of 33x.

• The implied "flawless execution assumption": every FEED customer converts to a firm order + commercialization in Romania / Poland / Canada launches on schedule + the Doosan plant ramps smoothly.

7.3 Three Valuation Scenarios

Conservative / Bear $2–4 (potential downside ~62–81%)

• Triggers: the Romania / Poland projects are delayed or canceled, the Doosan JV falls behind schedule, another ATM offering dilutes equity, or the SMR sector cools broadly

• Valuation assumption: valued only on net cash + NRC-certified IP ("liquidation value")

Fair / Base $5–8 (potential downside ~24–52%)

• Triggers: 1–2 FEED projects successfully convert to firm orders, the Doosan plant comes online, and revenue holds at $20–50M

• Valuation assumption: P/S of 50–80x (still high but close to pre-commercialization comparables such as GENB / IPSC)

Optimistic / Bull $15–25 (potential upside ~43–138%)

• Triggers: a hyperscaler (AWS / Microsoft / Google) signs a long-term SMR purchase agreement, 3+ firm orders are confirmed, and the Doosan plant comes online with the first module shipped

• Valuation assumption: P/S of 150–250x (narrative premium)

7.4 Calibrating the Fair Buy Price

The fair buy price ceiling is $4 (the upper edge of the bear range), meaning only when the share price falls below $4 do the odds favor the buyer — weighing downside risk (to bear $2) against upside potential (to the base midpoint of $6 or bull $15+). At the current $10.50, the stock sits in the base/bull transition zone and is far from offering a margin of safety.

8. Bull vs. Bear Debate

8.1 Core Bull Arguments

• Scarcity of NRC certification: the world's only SMR design with both NRC DCA and FDA — a "passport" for the SMR sector.

• SMRs are essential infrastructure for the AI power era: hyperscalers and industrial parks both need "small + safe + flexible" power sources.

• Doosan South Korean manufacturing JV: the first case of a global SMR module prefabrication plant.

• Early international-market positioning: Romania, Poland, Canada, South Korea — broader coverage than rivals.

• Fluor engineering endorsement: FLR is the world's second-largest engineering and construction company, providing construction assurance.

8.2 Core Bear Arguments

• The CFPP cancellation is an irreversible marker: the flagship project failed and the commercialization path broke down.

• No firm orders: every customer is at the FEED stage and can cancel at any time.

• Absent direct hyperscaler ties: Amazon → X-energy, Google → KAIROS, Microsoft → TerraPower — NuScale is in none of them.

• P/S of 195x is badly overextended: far above industrial companies nearing commercialization, a purely narrative-driven valuation.

• Cash burn rate vs. runway: annualized cash burn of $150–200M, remaining cash of ~$150M, with another dilutive ATM offering required.

• The NRC certification moat will erode: at least 3–5 rivals will obtain equivalent certification between 2026 and 2028.

• Frequent CEO turnover: after the CFPP cancellation, CEO Hopkins retired, and strategy has been unstable since the new CEO John Hopkins took over.

8.3 Combined Bull/Bear Assessment

The bull case centers on "NuScale's scarcity in the SMR sector + long-term strategic value," while the bear case centers on "doubtful near-term commercialization execution + a severe divergence between valuation and fundamentals." The current $10.50 share price still heavily reflects the bull scenario, but financial reality (revenue down 95.8% YoY, persistent cash burn) has begun to reflect the bear scenario. This "narrative vs. financials" scissor gap is the core reason for the "Avoid" rating.

9. Pre-Mortem Risk Checklist

Assuming the share price falls from the current $10.50 to $3 over the next 12–24 months, the after-the-fact attribution could be:

Major Macro Risks

• An SMR valuation bubble bursting in 2027-2028: if the entire SMR sector (NuScale + Oklo + NNE + LEU) still has no real commercial revenue in 2027, the market could cool across the board.

• NRC regulatory tightening: if the NRC adjusts its approval standards under a new U.S. administration, all SMR plans would be delayed.

• Restarts of traditional large nuclear plants: restarts of the U.S. Three Mile Island / Constellation plants are already underway and could capture data center power demand.

10. Zen Horizon Synthesis: Investment Judgment

10.1 Rating-Band Positioning

Referencing the 6-tier rating system:

• Business quality: ✗ Weak — revenue of $18.7M, EBITDA of -$203M, ROE of -83%, Q1 revenue down 95.8%

• Industry conditions: ~ Moderate — SMRs are a long-term trend but commercialization is at least 5 years out

• Management: ~ Moderate — strategy still being adjusted after the CFPP cancellation, with frequent CEO turnover

• Moat: ~ Moderate — NRC certification is a real moat but is eroding

• Valuation margin of safety: ✗ Badly insufficient — P/S of 195x, market cap of $3.6B vs. revenue of $18.7M

• Downside risk: ✗ High — any project delay or cancellation triggers -40%+

Overall assessment: "Avoid" rating — at the current $10.50, the price diverges severely from fundamentals, and there is no near-term catalyst to let fundamentals catch up to the valuation.

10.2 Specific Action Recommendations

Existing holders:

• Recommend gradually trimming to 0 or keeping a <1% position as a long-dated call option

• Set a stop-loss: trim the entire position if it breaks below $8 (the lower edge of the base range)

• Adding is not recommended, even on a short-term rebound

New buyers:

• Building a position at the current $10.50 is clearly not recommended

• Only consider buying if one of two conditions appears: the share price falls below $4 (the upper edge of the bear range)

• a confirmed "firm order" announcement (e.g., a hyperscaler strategic partnership + module purchase contract)

Long-term holders (5+ years):

• SMRs as a power-sector trend are worth watching long term, but NuScale is not the only SMR option

• Alternative names to consider: TerraPower (private, pending IPO), X-energy (private), Rolls-Royce SMR (embedded in RR.LSE)

• If committed to NuScale, recommend scaling in across three tranches at $8 / $6 / $4

10.3 Key Monitoring Signals

Indicators to watch closely over the next 6–12 months:

• Romania's RoPower project FID (Final Investment Decision): expected in 2026-2027, the single largest signal for NuScale's commercialization

• Doosan South Korean plant production timing: originally planned to begin manufacturing the first batch of modules in 2026

• 2026 Q2/Q3 revenue: whether it can halt the 95.8% year-over-year decline

• Cash and cash equivalents balance: a new ATM financing becomes mandatory once it breaks below $100M

• NRC certification of competitors: a DCA for any of BWRX-300, AP300, or SMR-300 is a negative signal

• Public hyperscaler SMR partnership announcements: any vendor other than NuScale signing a hyperscaler agreement is a negative signal

• Management public communication: whether the CEO's quarterly calls provide concrete milestones that "clarify the commercialization path"

11. Valuation Conclusion and Target Price Range

Current share price of $10.50 (2026-06-05 close)

• Conservative intrinsic value (Bear): $2–4 — triggered by a Romania project failure + large ATM dilution + an SMR sector cooldown

• Fair intrinsic value (Base): $5–8 — triggered by 1–2 FEED projects converting to firm orders + the Doosan plant coming online

• Optimistic intrinsic value (Bull): $15–25 — triggered by a hyperscaler long-term purchase agreement + 3+ firm orders confirmed

【Valuation Range】

• Bear: $2–4
• Base: $5–8
• Bull: $15–25

【Ideal/Fair Buy Price】

Fair buy price ceiling: $4 (the upper edge of the bear range) Trimming alert level: the current $10.50 price is itself a trimming signal Target buy price: below $4 (do not initiate a position before a firm order appears)

Rating: Avoid

Summary of Rationale: NuScale Power offers an "early-mover leader + NRC certification + Fluor engineering capability" combination and is the world's only SMR pure-play with both NRC DCA and FDA. But the scissor gap between its current financial profile (revenue of $18.7M, Q1 down 95.8% YoY, EBITDA of -$203M, ROE of -83%) and its $3.6 billion market cap (P/S 195x) has reached an unsustainable level.

The company's commercialization window opens no earlier than the 2030s — meaning the next 5 years are a pure cash-burn period with no certain revenue. The market has fully priced in "8–10 years of future sales under flawless execution," so any project delay, customer cancellation, or regulatory change triggers a sharp decline (it has already happened: the CFPP cancellation triggered -50%, and the stock fell 70% over the 2025-2026 year).

The core reason for "Avoid" rather than "Hold" is the severe divergence between valuation and fundamentals — a good story does not equal a good investment. SMRs as a "long-term trend" are real, but NuScale's "first-mover advantage" in this sector is being eroded by rivals such as TerraPower / X-energy / Holtec / KAIROS / Rolls-Royce SMR. The lack of strategic ties to hyperscalers (Amazon → X-energy, Microsoft → TerraPower, Google → KAIROS) is also a structural weakness. Reassess once the share price falls below $4, or once there is a confirmed firm-order announcement.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.